Mefloquine

Mefloquine: description, use and warnings

Mefloquine is a drug used to treat malaria, especially when other drugs have not been effective. The drug is taken orally and is available in various forms, including tablets, liquids and capsules. One of the best known trade names for mefloquine is Lariam.

Mefloquine works by blocking the proliferation of the malaria parasite in a person's blood. The drug may be effective in treating malaria caused by Plasmodium falciparum, which is the deadliest form of the malaria parasite.

However, like all medications, mefloquine has a number of warnings that must be taken into account when using it. First, mefloquine should not be used during pregnancy as it may harm the fetus. Also, the drug is not recommended for use in children under 6 months of age.

In addition, mefloquine should not be used concomitantly with beta blockers, as this may cause serious side effects. Also, the drug should not be prescribed to patients suffering from any mental disorders, as it may aggravate their condition.

Some patients may experience side effects with mefloquine, including nausea, headache, dizziness, insomnia, drowsiness, anxiety, and hallucinations. If you experience any side effects, you should consult your doctor immediately.

Overall, mefloquine is an effective drug for treating malaria, especially when other drugs have failed. However, before using it, it is necessary to carefully evaluate all risks and contraindications in order to avoid possible side effects and negative consequences.

Mefloquine, also known as Mefloquin, is a drug used to treat malaria in patients who are resistant to other drugs. It is prescribed orally and should be taken 1-2 hours before or after meals.

Mefloquine is not recommended for use during pregnancy or concomitantly with beta blockers. It should also not be prescribed to patients who suffer from mental disorders such as depression or schizophrenia.

Lariam is the trade name of the drug mefloquine. It comes in the form of tablets that are taken once a day. Lariam can be prescribed by a doctor only after consultation and if there are appropriate indications.

It is important to note that treating malaria with mefloquine may cause some side effects such as nausea, vomiting, headache, dizziness and insomnia. Allergic reactions such as rash or hives are also possible.

Overall, mefloquine is an effective drug for treating malaria and can be used in patients who do not respond to other drugs. However, as with any other drug, you must follow your doctor's recommendations and follow the dosage and frequency of use to avoid possible side effects.

Mefloquin (Lariam) is an antimalarial drug used to treat types of Plasmodium falciparum and Plasmodiun vivax malaria that are resistant to most other antimalarial drugs. It is prescribed internally. The patient should be aware of possible side effects and contraindications before starting mefloquine, especially if he is taking or has taken beta blockers (for example, beta blockers in cardiovascular medications), as well as mental illness.

Mefloquine was developed in the 1970s by pharmacologists in various laboratories, including GlaxoSmithKline in the UK. This drug acts on vectors, carriers of malaria parasites in the blood of an infected person, effectively blocking their activity. It significantly improves the patient's condition with all known malaria.

In the 20s of the 21st century, European doctors first assessed the effectiveness of mefloquine in the treatment of tropical diseases. There are several analogues of the drug, including Lavomac, sometimes used to prevent malaria. In different countries, Lari Am can be purchased only after the attending physician has issued a prescription. The patient's reaction to taking mefloquine may vary depending on the individual characteristics of the body. For example, people with liver problems may have a slow response to this medication, but it can be easily managed with supportive care. Regular monitoring by doctors is important - this is largely why doctors advise against taking mefloquine irresponsibly.